A denileukin diftitox (Ontak) associated retinopathy? [4]

British Journal of Ophthalmology

Volumn 90, Issue 8, 2006, Pages 1070-1071

  Ruddle, Jonathan B ^a   Harper, C A ^a,c,d   Honemann D ^b,c   Seymour, J F ^b,c   Prince, H M ^b,c  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CENTRE FOR EYE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DENILEUKIN DIFTITOX; IMMUNOGLOBULIN; PREDNISOLONE;

ADULT; BLURRED VISION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COLOR VISION; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG RESPONSE; HUMAN; LETTER; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETINA MACULOPATHY; RETINOPATHY; SCOTOMA; T CELL LYMPHOMA; VISUAL ACUITY;

ANTINEOPLASTIC AGENTS; DIPHTHERIA TOXIN; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; RETINAL DISEASES; VISION DISORDERS;

EID: 33746572032     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.091165     Document Type: Letter

References (8)

1. Morgan SJ, Seymour JF, Prince HM, et al. Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression. Clin Cancer Res 2004;10:3572-5.
2. Olsen E, Duvic M, Frankel A, et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 2001;19:370-88.
3. Thornton AM. Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2. Front Biosci 2006;11:921-7.
4. Takeuchi M, Keino H, Kezuka T, et al. Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice. Invest Ophthalmol Vis Sci 2004;45:1879-86.
5. Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 2005;139:780-94.
6. To KW, Thirkill CE, Jakobiec FA, et al. Lymphoma-associated retinopathy. Ophthalmology 2002;109:2149-53.
7. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 2004;4:5.
8. Sen HN, Chan CC, Caruso RC, et al. Waldenstrom's macroglobulinemia- associated retinopathy. Ophthalmology 2004;111:535-9.